Same industry

SPRY against four drug peers, a year at 100

5075100125150175Feb ’26MayAugNov ’26LLY+33.6%JNJ+36.7%ABBV+23.9%MRK+46.7%SPRY−51.9%

SPRY −51.9%. Merck +46.7%, Johnson & Johnson +36.7%, Eli Lilly +33.6%, AbbVie +23.9%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in SPRY’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

SPRY: stories, the record and filings →